Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicola Doldi"'
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 79:316-322
Vascular endothelial growth factor (VEGF) is potentially an important regulator of angiogenesis, particularly during the extensive tissue growth and remodeling that occur in utero. In the present study, we have investigated the role of VEGF during hu
Autor:
Paola Persico, Nicola Doldi, Enrico Papaleo, Lucia De Santis, Claudio Brigante, Augusto Ferrari, Guido Marelli, I. Cino, FM Fusi
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 22(7)
Poor ovarian response to standard in vitro fertilization-embryo transfer (IVF-ET) protocols or different regimens of treatment, as consequence of a diminished ovarian reserve, correlates strictly with patient age, elevated follicle-stimulating hormon
Autor:
Enrico Papaleo, Paola Persico, Nicola Doldi, Lucia De Santis, Elisa Rabellotti, Augusto Ferrari
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 20(3)
The decline of female fertility with advancing age is well documented. The aim of this study was to compare the ovarian performance after repeated ovarian stimulation cycles in women of different ages.Four hundred patients who started at least three
Autor:
Marco Magnoni, Stefano Coli, Paola Persico, Nicola Doldi, Alessandro Del Maschio, Giulio Melisurgo, Francesco De Cobelli, Attilio Maseri, Domenico Cianflone
Publikováno v:
International Journal of Cardiology. 115:E56-E57
Two previous reports have reported myocardial infarction during ovarian hyperstimulation syndrome, a complication of controlled ovarian stimulation characterized by ascites, pleural effusion, hemoconcentration and an increased thromboembolic risk, bu
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 10(4)
Ovulation was obtained in a 29-year-old woman affected by premature ovarian failure who had previously failed to respond to two attempts performed administering human menopausal gonadotropin or follicle-stimulating hormone after the spontaneous gonad